Integrating Parallel-Bias Metadynamics-Metainference and Relaxation Dispersion NMR to Resolve Hidden Conformational States Driving Toxin-Channel Recognition
Journal of the American Chemical Society · 12.08.2026 · 148 (31) · 32977-32992
DOI: 10.1021/jacs.5c22533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 01.08.2026. Verfasst von Chen Timsit Shmueli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Bar-Ilan University, Ramat-Gan52900, Israel. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation. Die Arbeit nennt 72 Literaturangaben. Gefördert von: U.S.-Israel Binational Science Foundation (BSF), Israel Ministry of Science, Technology and Space (MOST).
Abstract (Originalsprache)
Conformational dynamics in toxin inhibitors are an important contributor to ion channel affinity, yet toxin multidimensional energy landscapes remain largely unexplored. In the current work, we combine parallel-bias metadynamics-metainference (PBMetaD) simulations with relaxation dispersion NMR to define, at atomistic resolution, the thermodynamics and kinetics of Hui1, a de novo three disulfide toxin derived from the SAK-I family that targets K+-channels. Using the three χ3 disulfide dihedrals as collective variables, an extensive 48-replica well-tempered PBmetaD simulation (16.2 μs cumulative sampling) resulted in a fully converged three-dimensional (3D) free-energy surface comprising eight Hui1 conformers. These basins account for ∼96% of the bias-weighted ensemble and partition into four low- and four high-energy states separated by 7.5 kJ/mol associated with the (−) and (+)Cys12-Cys28 χ3 states, respectively. Transition-state theory identifies rota-isomerization of Cys3-Cys35 as the slowest, and therefore rate-determining, coordinate, while the analogous motions around Cys12-Cys28 and Cys17-Cys32 are ∼5-fold faster. 15N R1ρ relaxation dispersion NMR measurements confirmed these kinetics, identifying two structurally distinct residue clusters exhibiting intermediate and faster exchange processes. The Key Interaction Finder (KIF) approach reveals that Cys17-Cys32 conformation modifies connectivities within a dense interaction network between Cys17 and residues Gln14, Tyr23, Arg24, and Lys29, and correlates with the accessibility of residues Tyr23 and Arg24 of the helix-kink-helix region for interaction with the channel vestibule. Our work establishes PBMetaD as a powerful framework for mapping coupled disulfide and backbone dynamics in toxins and reveals specific conformers and interactions likely to control K+ channel recognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Chemistry, Bar-Ilan University, Ramat-Gan52900, Israel.
- Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan52900, Israel.
ORCID-Profile: Jordan H Chill
Förderung
- U.S.-Israel Binational Science Foundation (BSF)
- Israel Ministry of Science, Technology and Space (MOST)
Zitieren
APA
Shmueli, C. T., Gulman, M., Major, D. T., & Chill, J. H. (2026). Integrating Parallel-Bias Metadynamics-Metainference and Relaxation Dispersion NMR to Resolve Hidden Conformational States Driving Toxin-Channel Recognition. Journal of the American Chemical Society, 148(31), 32977-32992. https://doi.org/10.1021/jacs.5c22533
Vancouver
Shmueli CT, Gulman M, Major DT, Chill JH. Integrating Parallel-Bias Metadynamics-Metainference and Relaxation Dispersion NMR to Resolve Hidden Conformational States Driving Toxin-Channel Recognition. Journal of the American Chemical Society. 2026;148(31):32977-32992. doi:10.1021/jacs.5c22533
BibTeX
@article{Shmueli2026,
author = {Shmueli, Chen Timsit and Gulman, Miriam and Major, Dan Thomas and Chill, Jordan H},
title = {Integrating Parallel-Bias Metadynamics-Metainference and Relaxation Dispersion NMR to Resolve Hidden Conformational States Driving Toxin-Channel Recognition},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {31},
pages = {32977--32992},
doi = {10.1021/jacs.5c22533}
}
EUVIMED